Blog

Investors in Alcon Inc. ALC need to pay close attention to the stock based on moves in the options market lately. That is because the Feb. 20, 2026 $70.00 Call had some of the highest implied

UnitedHealth Group Incorporated UNH is again under scrutiny after questions were raised about how it handled loans to healthcare providers in the wake of the 2024 Change Healthcare cyberattack. UNH

CrowdStrike CRWD is seeing strong momentum in its Next Generation (Next-Gen) Security Information and Event Management (SIEM) as part of its mission to protect enterprises against evolving cyber

Guidewire Software, Inc. GWRE is slated to report fourth-quarter fiscal 2025 results on Sept. 4. Management expects revenues to be between $332 million and $340 million. The Zacks Consensus Estimate

Hilltop Holdings Inc. HTH shares touched a new 52-week high of $35.63 during Friday’s trading session. Over the past month, the stock has risen 15.6%, outperforming the industry, the Zacks Finance

Shares of Viking Therapeutics VKTX have lost over 20% in the past month, significantly underperforming the industry’s 1% growth. The stock has also underperformed the sector and the S&P 500 during

Bread Financial Holdings, Inc. BFH closed at $66.19 on Friday, near its 52-week high of $67.33. This proximity underscores investor confidence. It has the ingredients for further price

Pembina Pipeline Corporation PBA is a prominent midstream energy company operating across North America. Its main business revolves around moving, storing and processing oil, natural gas and natural

Palo Alto Networks PANW and CrowdStrike CRWD are both at the forefront of the cybersecurity space, playing key roles in guarding organizations from extensive cyberattacks. While Palo Alto Networks

Considering we have no major economic or Q2 earnings reports out ahead of today’s holiday-shortened week, it has the capacity to be quite impactful to the stock market. That’s because this is also

CorMedix’s CRMD lead drug, DefenCath (Taurolidine + Heparin), is currently its only marketed product that generates revenues for the company.

The FDA approved CorMedix’s DefenCath in late 2023 as

Transocean Inc. RIG, an offshore drilling contractor based in Switzerland, announced plans to offload five stacked rigs as part of its efforts to optimize its rig fleet. The rigs to be retired

C3.ai, Inc. AI is scheduled to report its first-quarter of fiscal 2026 results on Sept. 3, after the closing bell.In the last reported quarter, C3.ai’s top and bottom lines surpassed the Zacks

The Zacks Cable Television industry players are focusing on bundled offerings and on-demand programming to counter challenges from cord-cutting as consumers shift away from traditional pay-TV

Bristol Myers (BMY) has a strong oncology portfolio comprising blockbuster immune-oncology drug Opdivo, Opdivo Qvantig, and Yervoy, among others.

Opdivo is a key drug in BMY’s Growth Portfolio that

Glaukos Corporation GKOS continues to reshape the ophthalmology landscape, backed by a record-breaking first-half 2025 performance. The company posted revenues of $230.8 million, reflecting a 27.3%

PPL Corporation PPL aims to modernize the grid to advance electrification, and provide customers with more options to reduce energy use, including energy efficiency programs. In line with PPL's goal

Manulife Financial Corporation MFC closed at $30.75 on Friday, near its 52-week high of $33.07. This proximity underscores investor confidence. It has the ingredients for further price

Costco Wholesale Corporation’s COST last reported quarter painted a compelling picture with strong traffic growth that could be an important signal for the holiday season. Comparable traffic, or

Eli Lilly and Company LLY has gained tremendous market value in the past 2-3 years due to the success of its popular GLP-1 drugs, Mounjaro for type II diabetes and Zepbound for obesity.

However

The market expects Dave & Buster's (PLAY) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended July 2025. This widely-known consensus

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, September 2nd:

Sportradar Group SRAD:This company which is a provider of sports betting and

Corcept Therapeutics’ CORT sole-marketed drug, Korlym (mifepristone), which is approved for treating Cushing's syndrome or endogenous hypercortisolism, has been performing well. The company’s top

Investors in CGI Group, Inc. GIB need to pay close attention to the stock based on moves in the options market lately. That is because the Nov 21, 2025 $75.00 Put had some of the highest implied